The University of Chicago Medicine’s Comer Children’s Hospital is home to one of the most integrated pediatric oncology networks in the Chicagoland area. The hospital brings together the brightest minds in advanced pediatric cancers, allow young patients access to some of today’s latest and most advanced treatment options.
In many cases, a multidisciplinary panel of pediatric oncology experts convenes to craft the best possible treatment plan for each child. When surgery is necessary, our pediatric surgeons offer a wide range of treatment options.
The University of Chicago Medicine Comer Children's Hospital is one of the few medical centers in the United States to offer hyperthermic intraperitoneal chemotherapy (HIPEC) for children, adolescents and young adults with certain advanced abdominal tumors, including difficult-to-treat cancers such as desmoplastic small-round-cell tumors. The goal of HIPEC is to eradicate any small tumor deposits that cannot be seen or safely removed by the surgeon.
Our pediatric surgeons are also experienced in the latest minimally invasive techniques that allow children to return to their daily lives with less pain and over a short amount of time.
In addition to our clinical offerings, Comer Children’s Hospital is a leading participant in the Children’s Oncology Group of North America, which gives young cancer patients increased access to new and emerging therapies that are not yet widely available.